Pharmaceutical Regulatory Affairs in Africa: 2-Day Online Training Course (July 23-24, 2024) with CPD Certification
May 30, 2024 04:18 ET
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in Africa Training Course" conference has been added to ResearchAndMarkets.com's offering. The value of the African...
Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
May 29, 2024 15:27 ET
|
Recursion Pharmaceuticals
SALT LAKE CITY, May 29, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today published in Nature...
Best Peptides Company of 2024 Announced As Limitless Biotech
May 29, 2024 09:00 ET
|
Limitless Biotech
Gulf Breeze, FL, May 29, 2024 (GLOBE NEWSWIRE) -- Limitless Biotech, a leading provider of high-quality peptides, proudly announces its ascension as the best peptide company in the industry. Through...
PSMF Online Training Course: A Technical Training Program on Creating and Maintaining Pharmacovigilance System Master File (PSMF)
May 28, 2024 04:43 ET
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "PSMF Online Training - A Technical Training Program on Creating and Maintaining Pharmacovigilance System Master File (PSMF)" training has been added to ...
PSUR/PBRER Online Training Program: Professional Training on Developing, Managing and Reporting of PSURs/PBRERs in Pharmacovigilance
May 28, 2024 04:41 ET
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "PSUR/PBRER Online Training - Professional Training Program on Developing, Managing and Reporting of PSURs/PBRERs in Pharmacovigilance" training has been...
Pharmaceutical Document Management 3 Day Online Training Course: A Global Regulatory Approach (August 12-14, 2024)
May 28, 2024 03:44 ET
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Document Management Training Course - A Global Regulatory Approach" training has been added to ResearchAndMarkets.com's offering. In...
Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients
May 23, 2024 17:09 ET
|
Ivy Brain Tumor Center
Phoenix, AZ, May 23, 2024 (GLOBE NEWSWIRE) -- Results will be presented at American Society of Clinical Oncology (ASCO) Annual MeetingMedian overall survival was 20.3 months, nearly doubling the...
Syntekabio to Showcase Advanced AI Drug Discovery Technologies at BIO International Convention 2024
May 23, 2024 10:00 ET
|
Syntekabio USA Inc.
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery pioneer, today announced its participation at the BIO International Convention...
Pattern Announces Commencement of Synergy and Efficacy Testing for Promising High-grade Serous Ovarian Cancer Program Combinations
May 22, 2024 08:30 ET
|
PATTERN COMPUTER, INC.
REDMOND, Wash., May 22, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) proudly announces the initiation of synergy and efficacy testing for two promising drug...
Pattern to Present at 2024 BIO International Convention
May 21, 2024 08:30 ET
|
PATTERN COMPUTER, INC.
REDMOND, Wash., May 21, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that Mark R. Anderson, Chairman and CEO, will present at the upcoming 2024 BIO...